HSBC Holdings’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $494K | Buy |
51,991
+3,057
| +6% | +$29.1K | ﹤0.01% | 1719 |
|
|
2025
Q1 | $343K | Sell |
48,934
-2,602
| -5% | -$18.3K | ﹤0.01% | 1860 |
|
|
2024
Q4 | $601K | Buy |
51,536
+16,569
| +47% | +$193K | ﹤0.01% | 1687 |
|
|
2024
Q3 | $722K | Sell |
34,967
-1,664
| -5% | -$34.4K | ﹤0.01% | 1494 |
|
|
2024
Q2 | $813K | Buy |
36,631
+2,067
| +6% | +$45.9K | ﹤0.01% | 1439 |
|
|
2024
Q1 | $951K | Buy |
34,564
+14,284
| +70% | +$393K | ﹤0.01% | 1446 |
|
|
2023
Q4 | $624K | Buy |
20,280
+152
| +0.8% | +$4.68K | ﹤0.01% | 1559 |
|
|
2023
Q3 | $635K | Buy |
+20,128
| New | +$635K | ﹤0.01% | 1457 |
|
|
2023
Q2 | – | Sell |
-21,571
| Closed | -$797K | – | 2201 |
|
|
2023
Q1 | $797K | Buy |
21,571
+13,075
| +154% | +$483K | ﹤0.01% | 1485 |
|
|
2022
Q4 | $292K | Buy |
+8,496
| New | +$292K | ﹤0.01% | 2110 |
|
|
2020
Q4 | – | Sell |
-23,091
| Closed | -$477K | – | 2606 |
|
|
2020
Q3 | $477K | Buy |
23,091
+3,022
| +15% | +$62.4K | ﹤0.01% | 1587 |
|
|
2020
Q2 | $422K | Sell |
20,069
-1,769
| -8% | -$37.2K | ﹤0.01% | 1591 |
|
|
2020
Q1 | $261K | Buy |
+21,838
| New | +$261K | ﹤0.01% | 1727 |
|